Families with Wilson's disease in subsequent generations: Clinical and genetic analysis

Wilson's disease is an inherited autosomal recessive disorder of copper metabolism. The prevalence of Wilson's disease in most populations is approximately 1 in 30,000. The risk for offspring is 0.5%. The aim of this study was to establish the frequency of disease among offspring of a cohort of Wilson's disease patients.

[1]  M. Hutchinson,et al.  Epidemiology of Wilson's disease in Ireland , 2014, Movement disorders : official journal of the Movement Disorder Society.

[2]  J. Hardy,et al.  Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel , 2013, Movement disorders : official journal of the Movement Disorder Society.

[3]  A. Członkowska,et al.  Concordance rates of Wilson’s disease phenotype among siblings , 2013, Journal of Inherited Metabolic Disease.

[4]  M. Hallett,et al.  Phenomenology and classification of dystonia: A consensus update , 2013, Movement disorders : official journal of the Movement Disorder Society.

[5]  Magnus Rattray,et al.  A genetic study of Wilson's disease in the United Kingdom. , 2013, Brain : a journal of neurology.

[6]  S. Drapier,et al.  Neurological Wilson's disease lethal for the son, asymptomatic in the father , 2013, Movement Disorders.

[7]  S. Schneider,et al.  Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. , 2012, American journal of human genetics.

[8]  F. Baas,et al.  Phenotypes and genetic architecture of focal primary torsion dystonia , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  M. Trauner,et al.  Identification of a novel Wilson disease gene mutation frequent in Upper Austria: a genetic and clinical study , 2012, Journal of Human Genetics.

[10]  A. Członkowska,et al.  Apolipoprotein E gene (APOE) genotype in Wilson's disease: impact on clinical presentation. , 2012, Parkinsonism & related disorders.

[11]  D. Maraganore,et al.  Mutations in CIZ1 cause adult onset primary cervical dystonia , 2012, Annals of neurology.

[12]  A. Członkowska,et al.  Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease. , 2011, Journal of hepatology.

[13]  A. Członkowska,et al.  Wilson's disease in consecutive generations of one family. , 2011, Parkinsonism & related disorders.

[14]  A. Członkowska,et al.  Influence of IL-1RN Intron 2 Variable Number of Tandem Repeats (VNTR) Polymorphism on the Age at Onset of Neuropsychiatric Symptoms in Wilson's Disease , 2011, The International journal of neuroscience.

[15]  A. Członkowska,et al.  Middle-aged heterozygous carriers of Wilson’s disease do not present with significant phenotypic deviations related to copper metabolism , 2010, Journal of Genetics.

[16]  A. Taly,et al.  Wilson's disease: An Indian perspective. , 2009, Neurology India.

[17]  A. Członkowska,et al.  Monozygotic female twins discordant for phenotype of Wilson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[18]  M. Schaefer,et al.  Analysis of the human Atox 1 homologue in Wilson patients. , 2008, World journal of gastroenterology.

[19]  D. Timmann,et al.  “Pseudodominant inheritance” of ataxia with ocular apraxia type 2 (AOA2) , 2008, Journal of Neurology.

[20]  M. Raycheva,et al.  Wilson’s disease in two consecutive generations in a Bulgarian Roma family , 2007, Journal of Neurology.

[21]  W. Stremmel,et al.  Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. , 2006, Archives of neurology.

[22]  M. Schaefer,et al.  Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels. , 2006, World journal of gastroenterology.

[23]  J. C. Wilkinson,et al.  XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. , 2006, Molecular cell.

[24]  A. Członkowska,et al.  p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[25]  A. Członkowska,et al.  Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease , 2005, Clinical genetics.

[26]  E. Tsafantakis,et al.  Wilson Disease: High Prevalence in a Mountaineous Area of Crete , 2005 .

[27]  Z. Tulassay,et al.  The Other Mutation Is Found: Follow-Up of an Exceptional Family with Wilson Disease , 2004, American Journal of Gastroenterology.

[28]  D. Cox,et al.  Diagnosis and phenotypic classification of Wilson disease 1 , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[29]  A. Brice,et al.  Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations , 2001, Neurology.

[30]  M. Caggana,et al.  Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. , 2001, Annals of human genetics.

[31]  P. Ferenci,et al.  Wilson disease in two consecutive generations: an exceptional family , 2001, American Journal of Gastroenterology.

[32]  G. Brewer.  Wilson’s Disease: A Clinician’s Guide to Recognition, Diagnosis, and Management , 2001 .

[33]  P. Bauer,et al.  High prevalence of the very rare wilson disease gene mutation Leu708Pro in the Island of Gran Canaria (Canary Islands, Spain): A genetic and clinical study , 2000, Hepatology.

[34]  C. Madl,et al.  The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. , 2000, Brain : a journal of neurology.

[35]  A. Angius,et al.  Molecular characterization of Wilson disease in the Sardinian population—Evidence of a founder effect , 1999, Human mutation.

[36]  P. Ferenci,et al.  Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. , 1995, Gastroenterology.

[37]  H. Nazer,et al.  Wilson's Disease. , 1991, Annals of Saudi medicine.

[38]  L. Cavalli-Sforza,et al.  Wilson's disease in Israel: a genetic and epidemiological study , 1990, Annals of human genetics.

[39]  A. Harding,et al.  'Pseudo-dominant' inheritance in Friedreich's ataxia. , 1981, Journal of medical genetics.

[40]  J. Samochowiec,et al.  Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease. , 2013, JIMD reports.

[41]  P. Swanson,et al.  An exceptional family with three consecutive generations affected by Wilson disease. , 2013, JIMD reports.

[42]  Rappold,et al.  Human Molecular Genetics , 1996, Nature Medicine.

[43]  A. Członkowska,et al.  Observations on copper metabolism in Wilson's disease. , 1973, Acta Universitatis Carolinae. Medica. Monographia.